All Pharma News
Formosa and Tabuk sign deal for FDA-approved ophthalmic suspension

Formosa and Tabuk sign deal for FDA-approved ophthalmic suspension
PHARMACEUTICAL TECHNOLOGY
10 May 2024
Share Share
Formosa, Tabuk Deal For Ocular Surgery Ophthalmic Suspension

Formosa, Tabuk Deal For Ocular Surgery Ophthalmic Suspension
PR NEWSWIRE
09 May 2024
Share Share
US FDA approves Eyenovia`s eye drug, Formosa Pharma says

US FDA approves Eyenovia`s eye drug, Formosa Pharma says
REUTERS
05 Mar 2024
Share Share
Formosa Pharmaceuticals Announces Licensing Agreement with Cristália

Formosa Pharmaceuticals Announces Licensing Agreement with Cristália
PR NEWSWIRE
26 Jan 2024
Share Share
Formosa sells Brazilian rights to near-approval eye drug

Formosa sells Brazilian rights to near-approval eye drug
FIERCE BIOTECH
26 Jan 2024
Share Share
Formosa Pharma inks $86 M worth ophthalmology deal with American firm Eyenovia

Formosa Pharma inks $86 M worth ophthalmology deal with American firm Eyenovia
BIOSPECTRUM ASIA
21 Aug 2023
Share Share
Formosa Announces Agreement with Eyenovia for the Commercialization of APP13007

Formosa Announces Agreement with Eyenovia for the Commercialization of APP13007
PR NEWSWIRE
16 Aug 2023
Share Share
Formosa, AimMax submit NDA to FDA for new pain therapy

Formosa, AimMax submit NDA to FDA for new pain therapy
PHARMACEUTICAL-TECHNOLOGY
08 May 2023
Share Share
Formosa & AimMax Announce the NDA Submission to the US FDA for APP13007

Formosa & AimMax Announce the NDA Submission to the US FDA for APP13007
PR NEWSWIRE
04 May 2023
Share Share
Formosa Pharma Announces Development Collaboration Agreement with Eyenovia

Formosa Pharma Announces Development Collaboration Agreement with Eyenovia
PR NEWSWIRE
15 Feb 2023
Share Share